Limitations to the 6-minute walk test in dermatomyositis with interstitial lung disease in comparison with idiopathic interstitial pneumonia

Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine

Volumn 7, Issue 1, 2013, Pages

  Someya, Fujiko ^a   Mugii, Naoki ^b  

^a KANAZAWA UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Dermatomyositis; Exercise capacity; Idiopathic interstitial pneumonia; Interstitial lung disease

Indexed keywords

CARBON MONOXIDE; CREATINE KINASE;

6 MINUTE WALK TEST; ADULT; ARTICLE; CLINICAL ARTICLE; DERMATOMYOSITIS; DYSPNEA; FEMALE; FUNCTION TEST; HUMAN; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; MALE; MUSCLE WEAKNESS; OXYGEN SATURATION; OXYGEN TENSION; VITAL CAPACITY;

EID: 84873158173     PISSN: 11795484     EISSN: None     Source Type: Journal    
DOI: 10.4137/CCRPM.S10764     Document Type: Article

References (20)

1. Callen JP, Wortmann RL. Dermatomyositis. Clin Dermatol. 2006;24: 363-73.
2. Ikeda N, Takahashi K, Yamaguchi Y, Inasaka M, Kuwana M, Ikezawa Z. Analysis of dermatomyositis-specific autoantibodies and clinical characteristics in Japanese patients. J Dermatol. 2011;38:973-9.
3. Hamaguchi Y, Kuwana M, Hoshino K, et al. Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis. Arch Dermatol. 2011;147:391-8.
4. Saketkoo LA, Ascherman DP, Cottin V, Christopher-Stine L, Danoff SK, Oddis CV. Interstitial lung disease in idiopathic inflammatory myopathy. Curr Rheumatol Rev. 2010;6:108-9.
5. Mukae H, Ishimoto H, Sakamoto N, et al. Clinical differences between interstitial lung disease associated with clinically amyopathic dermatomyositis and classic dermatomyositis. Chest. 2009;136:1341-7.
6. Wiesinger GF, Quittan M, Nuhr M, et al. Aerobic capacity in adult dermatomyositis/polymyositis patients and healthy controls. Arch Phys Med Rehabil. 2000;81:1-5.
7. de Salles Painelli V, Gualano B, Artioli GG, et al. The possible role of physical exercise on the treatment of idiopathic inflammatory myopathies. Autoimmunity Rev. 2009;8:355-9.
8. Villalba WO, Sampaio-Barros PD, Pereira MC, et al. Six-minute walk test for the evaluation of pulmonary disease severity in scleroderma patients. Chest. 2007;131:217-22.
9. Garin MC, Highland KB, Silver RM, Strange C. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma. J Rheumatol. 2009;36:330-6.
10. Nishiyama O, Kondoh Y, Kimura T, et al. Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology. 2008;13: 394-9.
11. Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med. 1998;158:1384-7.
12. Jastrzebski D, Gumola A, Gawlik R, Kozielski J. Dyspnea and quality of life in patients with pulmonary fibrosis after six weeks of respiratory rehabilitation. J Physiol Pharmacol. 2006;57(Suppl 4):139-48.
13. Buch MH, Denton CP, Furst DE, et al. Submaximal exercise testing in the assessment of interstitial lung disease secondary to systemic sclerosis: reproducibility and correlations of the 6-min walk test. Ann Rheum Dis. 2007;66:169-73.
14. du Bois RM, Weycker D, Albera C, et al. Six-minute-walk test in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011;183:1231-7.
15. Manali ED, Lyberopoulos P, Triantafillidou C, et al. MRC chronic Dyspnea Scale: Relationships with cardiopulmonary exercise testing and 6-minute walk test in idiopathic pulmonary fibrosis patients: a prospective study. BMC Pulmonary Med. 2010;10:32-41.
16. Lama VN, Flaherty KR, Toews GB, et al. Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med. 2003;168:1084-90.
17. de Oliveira NC, dos Santos Sabbag LM, Ueno LM, et al. Reduced exercise capacity in systemic sclerosis patients without pulmonary involvement. Scand J Rheumatol. 2007;36:458-61.
18. Wagner PD. Skeletal muscles in chronic obstructive pulmonary disease: deconditioning, or myopathy? Respirology. 2006;11:681-6.
19. Da Silva JAP, Jacobs JWG, Kirwan JR, et al. Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data. Ann Rheum Dis. 2006;65:285-93.
20. Alhamad EH, Shaik SA, Idrees MM, Alanezi MO, Isnani AC. Outcome measures of the 6 minute walk test: relationships with physiologic and computed tomography findings in patients with sarcoidosis. BMC Pulmonary Med. 2010;10:42-8.